OPTIMIZERx Corporation Files Form S-1 Registration Statement
11 November 2008 - 4:02PM
Marketwired
OPTIMIZERx Corporation (PINKSHEETS: OPRX) today announced that on
Monday November 10, 2008, the Company filed a Form S-1 Registration
Statement with the United States Securities Exchange Commission.
David Harrell, CEO of OPTIMIZERx, commented, "The filing of our
Form S-1 is simply the next step in providing transparency and
accountability to our shareholders. When we completed our reverse
merger in the spring, we committed to our shareholders that we
would work diligently to become a reporting company. After we
receive notice from the regulators that our registration statement
is effective, and upon meeting the various listing requirements,
our goal is to list the trading of our stock with NASDAQ."
About OPTIMIZERx Corporation
OPTIMIZERx provides unique platforms to help patients better
afford and comply with their medicines therapies and healthcare
products, while offering pharmaceutical and healthcare companies
effective methods to expand patient awareness, access and adherence
to their brands. The Company's consumer website,
www.OPTIMIZERx.com, and its permanent subscriber base, continues to
grow each month and is quickly becoming the preferred way to access
branded prescription savings and support programs. Additionally,
OPTIMIZERx has integrated and developed peripheral offerings,
including OFFERx(TM) offer management system and the ADHERxE(TM)
platform to allow more brands to participate in promoting a new
trial or co-pay program. For additional information on OPTIMIZERx,
including an investor fact sheet, see
www.firstcapitalinvestors.com.
'SAFE HARBOR'
This press release contains forward-looking statements within
the definition of Section 27A of the Securities Act of 1933, as
amended and such section 21E of the Securities Act of 1934,
amended. These forward-looking statements should not be used to
make an investment decision. The words 'estimate,' 'possible' and
'seeking' and similar expressions identify forward-looking
statements, which speak only as to the date the statement was made.
The company undertakes no obligation to publicly update or revise
any forward-looking statements, whether because of new information,
future events, or otherwise. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted, or quantified. Future events and actual results could
differ materially from those set forth in, contemplated by, or
underlying the forward-looking statements. The risks and
uncertainties to which forward-looking statements are subject
include, but are not limited to, the effect of government
regulation, competition and other material risks.
Contact: Investor Relations First Capital Investors, Inc. Email
Contact 321-221-2910
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024